LATS1 and breast carcinoma: There is additionally evidence that various upstream components of the Hippo pathway can act independently of the downstream transcriptional module, with NF2 exhibiting pleiotropy in mesothelioma [303] and LATS1/2 acting as a regulator of ERα stability in breast cancer cells independent of kinase activity [304].